Impact of UFT on Tumoral TS and DPD Levels in Colorectal Cancer
October 1st 2000This was an open lable, pilot translational clinical pharmacology study of a brief (7 day) course of UFT, 300 mg/m²/day, in combination with leucovorin, 90 mg/day, in six patients with newly diagnosed advanced colorectal cancer.